Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,363,307
-$33,286 QoQ
Shares Held
8,699
-4.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#533
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avidian Wealth Enterprises, LLC holds $46,072,826 across 12 Drug Manufacturers - General names. NVS ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,670 | $10,399,058 | |
| 2 | JNJ |
Johnson & Johnson
|
38,004 | $9,651,875 | |
| 3 | ABBV |
AbbVie Inc.
|
35,331 | $8,890,692 | |
| 4 | AMGN |
Amgen Inc
|
13,323 | $4,824,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
33,988 | $4,367,458 | |
| 6 | PFE |
Pfizer Inc
|
79,424 | $1,912,529 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
14,589 | $1,843,174 | |
| 8 | NVO |
Novo Nordisk A S
|
31,634 | $1,516,533 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,363,307 | 8,699 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,396,593 | 9,143 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,077,040 | 7,812 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,016,558 | 7,927 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $937,706 | 7,749 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $853,825 | 7,659 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $725,835 | 7,459 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $910,153 | 7,913 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $831,559 | 7,811 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $707,483 | 7,314 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $807,659 | 7,999 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $818,139 | 8,032 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $861,569 | 8,538 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $752,468 | 8,179 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $714,147 | 7,872 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $598,350 | 7,872 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $655,868 | 7,759 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $675,850 | 7,702 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $833,589 | 9,530 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $414,951 | 5,074 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $458,663 | 5,027 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $440,734 | 5,156 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $535,040 | 5,666 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $482,280 | 5,546 | Shares | Sole | 2021-02-03 | |
| 2020-06-30 | $409,711 | 4,691 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $353,050 | 4,282 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||